Home Lifestyle Financial Results | Nestle expects to increase sales | ABB exceeds expectations | Novartis is showing strong growth

Financial Results | Nestle expects to increase sales | ABB exceeds expectations | Novartis is showing strong growth

by admin

Basics of economics Every day, find selected information from a world in complete transformation.

News ➡ Nestlé reported a 5.6% increase in sales in the first quarter | Nestle advertisement 5.6% increase from sales to first trimester By increasing prices to offset inflation. The organic growth rate reached 9.3%.. However, sales volume decreased by 0.5%. The group confirmed its targets for 2023 with sales growth expected between 6% and 8%. Nestlé also created a joint venture with investment fund PAI Partners for frozen pizzas in Europe.

In the form of ➡ ABB: First-quarter net profit up 72% to $1 billion | swiss-swedish industrial conglomerate, ABBannounced Tuesday Better results than expected for the first quarter of 2023. Net profit increased by 72% compared to the same period of the previous year, reaching $1 billion (905 million euros). New orders increased by 1% to reach $9.4 billionWhile revenue grew by 13% to approximately $7.9 billion.


Analysts polled by Swiss agency AWP had forecast a profit of $877 million on revenue of $7.5 billion. For the second quarter, the group expects double-digit revenue growth. In addition, ABB announced that it would remove its Certificates of Depositary in sotc exchange to New York, which provides access to foreign stocks on the American Stock Exchange. The last trading day for these certificates of deposit is set for May 23.

Novartis, GettyImages

He follows ➡ Novartis revises its forecast for 2023 upwards | Novartis Announced Tuesday Strong growth in the first quarter of 2023with Net profit rose 3% to $2.3 billion (2.1 billion euros) and a sales volume of approx $13 billion, up 3% compared to the same period last year. This growth is supported by the company’s pharmaceutical division, whose sales increased by 7% to $10.6 billion excludes effects exchangeand the Sandoz Corporationwhich must be submitted in sotc exchange.

Novartis also improved its guidance for 2023 to “mid single digit” revenue and “high single digit” operating income growth, building on the strong growth momentum seen in the first quarter. This performance is ensured by the group’s leading brands, such as from EntrestoAnd Kisqali And Kisemptaas well as growth in Europe from the affiliated company SandozBuilding on the momentum of last year’s launches.

Related News

Leave a Comment